Radioactive implant induced x-ray emission technique for noninvasive determination of iodine content in thyroid: experimental study.
A new technique, radioactive implant x-ray emission spectrometry to determine the in vivo iodine content of the human thyroid is proposed. The variations of counting rate and effective excitation efficiencies of I K alpha (28.6 keV) with iodine content, thyroid volume and skin-thyroid distance were studied for the 201Tl source to examine the properties of excitation and photon attenuation. As a result, the gland depth and volume could be estimated from the peak ratios of 30.7 keV/167.6 keV and 28.6 keV/167.6 keV. Using a 1 MBq 201Tl implant source, the detectable minimum iodine concentration found was approximately 70 micrograms/g for 2000 s measuring time in the phantom experiment. The effectiveness of the RIXE technique is discussed. It was concluded that the 201Tl RIXE spectrometry might serve to determine the in vivo iodine content of the human thyroid.
D000576:Americium / Q000008:administration & dosage; D006801:Humans; D007455:Iodine / Q000032:analysis*; D008953:Models, Anatomic; D011868:Radioisotopes / Q000008:administration & dosage*; D013052:Spectrometry, X-Ray Emission / Q000379:methods*; D013667:Technetium / Q000008:administration & dosage; D013793:Thallium / Q000008:administration & dosage; D013961:Thyroid Gland / Q000032:analysis*
D011868:Radioisotopes; D013667:Technetium; D007455:Iodine; D013793:Thallium; D000576:Americium